Overview

Oxidative Stress in Asthma

Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
40% of all asthma patients in the US are obese. Obese asthmatics have more severe disease than lean asthmatics and do not respond as well to conventional anti-inflammatory therapies. This proposal will utilize 3D functional imaging with 129XeMRI and single cell RNA sequencing to study mechanisms driving regional airway remodeling and fibrosis in obese asthma subjects and in preclinical models of obese asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Bastiaan Driehuys
Collaborator:
National Institutes of Health (NIH)